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Abstract   
Background: Since the first report of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), widely known 
as COVID-19, in late December 2019, it has spread worldwide. The eventual return of new normal has started to 
happen in most countries where the COVID-19 curve has flattened, and Assisted reproduction technology (ART) 
services are eventually resuming. Well-organized ART (embryology/andrology) laboratories safeguard the wellbeing of 
all staff, patients, and their gametes/embryos. 
Main body: A well-organized pandemic management plan must be implemented in anticipation of possible 
subsequent COVID-19 waves. Apart from local and national guidelines, some mandatory changes need to be taken 
into considerations that will allow us to overcome the fear of this deadly pandemic, work smoothly and stop any 
possible transmission without comprising the quality control for successful treatment. These mandatory changes 
include conserving different supplies, reducing manpower needs, and various protective measures for non-clinical and 
clinical staff, patients, and gametes/embryos. 
Conclusion: The current pandemic of COVID-19 suggests a well-organized action-oriented emergency plan to assure 
the wellbeing of all stakeholders. 
Keywords: COVID-19, Infertility, Response plan, IVF Laboratory, embryology, and Andrology Laboratories, India 
 
Background  
Within the last two decades, severe acute respiratory syndrome 
(SARS) and the Middle East respiratory syndrome (MERS) 
emerged as highly pathogenic and were responsible for major 
respiratory disease outbreaks. The recent deadly human  
Coronavirus (SARS-CoV-2) in cells is mediated by using 
angiotensin-converting enzyme 2 (ACE2) receptors by binding 
with a 1273 amino acid, long spike (S) viral protein protruding 
a 'corona' like appearance [1]. ACE2 receptors have been 
reported in Leydig, Sertoli, theca, granulosa cells of the human 
ovary, and spermatogonia of the human testis [2]. Globally, the 
health care system has been under an unprecedented strain 
introduced by the COVID-19 pandemic, and to stop the 
spreading of SARS-CoV-2, all non-essential care treatments 
were discontinued in numerous countries.  Although assisted 
reproductive technology (ART) also comes under the "non-
essential" healthcare system, various international groups, and 
bodies such as the American Society for Reproductive Medicine 
(ASRM), European Society of Human Reproduction and 
Embryology (ESHRE), and British Fertility Society (BFS), 
raised the concern regarding discontinuing fertility treatments 
resulting in generating a difference of opinion to what to be 
considered as essential or non-essential. After the world health 
organization (WHO) announced COVID-19 as a pandemic, 
fertility treatments were suspended, as recommended by various 
fertility societies, including ASRM, ESHRE BFS, raising 
anxieties in patients with fertility issues [3]. Although, from 
June 2020 onwards, there has been some resumption in the 
ART treatment, however, there are still discrepancies regarding 
the manner and the extent of ART treatment to be offered. 
Although the COVID-19 pandemic has affected both public and 
private centers, all fertility societies have gradually 
recommended the resumption of ART treatment, highlighting 
the early identification of patients requiring immediate 
treatment [4]. 
 
Positive Hope  
The viral presence in the reproductive tract in males affects 
fertility and highly increases the risks of sexually transmitted 
infections [5]. Up to date, the extent of existence and replication 
of viruses in the male reproductive system is not clear [6]; 
however, the Zika virus has been reported to stay up to one year 
in males after recovering from infection [7]. Salam and Horby 
[8] reported the transmission of 27 viruses in male semen [8]. 
Moreover, structural stability plays a vital role in this shedding 
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process. Li D et al. [9] reported the transmission of COVID-19 
into semen [9]; however, biases like low sample size, the stage 
of infection, and the time of the study (COVID-19 pandemic) 
altered the result. Furthermore, there was no cross-
contamination of cryopreserved semen samples has been 
reported yet.  
 
Mandatory changes  
Per the centers for disease control and prevention (CDC) safety 
standards, it was mandatory for all front-line staff to use 
personal protective equipment (PPE), including face masks, 
disposable laboratory coats, eye protectors, and shoe covers. At 
least two alternate mini-teams should be made available to limit 
the spread of the virus if any staff is infected. In case of any 
staff being infected, at least two alternate mini-teams should be 
available to limit the spread of the virus. Proper safety measures 
should be followed, and all staff should be appropriately 
educated. Proper face masks and distance should be maintained 
and contact with patients should be avoided. Non-laboratory 
(clinicians and nurses) and non-medical (security, technicians) 
persons should be trained for liquid nitrogen tank filling under 
video conference call with embryologists for cryopreserved 
samples if lab staff is quarantined. Proper sanitization of 
equipment, devices, and workspace with detergents, UV 
irradiation, and disinfectants with proven efficiency should be 
performed after every procedure. In times of peak spread, the 
use of telehealth technologies in video conferencing and phone 
consultation should be given preference over the in-person face-
to-face interactions. Honest counseling about the cycle 
cancellation in case of COVID-19 positive test before the 
stimulation, in-between stimulation, and before trigger should 
be done in advance. Apart from this, as the effect of COVID-19 
infection on sperm, oocytes, embryos, implantation, and 
miscarriages is still unknown, it should also be discussed with 
the patient.  
All the persons (both staff and patients) entering any fertility 
clinic should fill the ART Triage questionnaire to understand 
any potential source of infection [10]. Any potential infectious 
case should be referred to COVID-19 testing according to local 
and national guidelines. Some Basic recommendations as an 
early-level response plan in pre-pandemic management for 
ART laboratories are listed below in Table 1.  
 
Andrology Laboratory Recommendations  
As some studies have reported the possible viral transmission in 
either semen or testicular sample, proper necessary measures 
should be taken. Some possible recommendations needed to be 
made summarized in Table 2.  
 
Embryology Laboratory Recommendations  
For smooth working of embryology laboratories in COVID-19 
pandemic, certain recommended precautions that need to be 
taken are summarized in Table 3.  
 
Non-laboratory Recommendations  
All the possible transmission ways should be blocked starting 
from by proper 6-step hand-washing at entry before entering the 
laboratory, use of PPE kits by all staff, well-organized mini-
teams of staff, cutting down in-person interactions within 
laboratory staff and with patients, a proper social distancing 
between patients and staff, introduction of alarm sensors system 
in liquid nitrogen tanks, proper backup of all essential 
commodities, and removing outer packing of all media. 
Moreover, consumables should be adequately monitored and 
removed before taking inside the laboratory, avoiding 
unnecessary movement, extra mobile air filters, shearing of 
pens and papers should be discouraged, and door handle should 
be cleaned frequently.  
 
Table 1: Early-level recommendations for ART laboratories to stop COVID-19 transmission.   
Recommendation  Basis of evidence 
A spare cryogenic storage tank should be available to store 
sufficient liquid nitrogen in case of possible Lockdown. 
Practice Committees of the American Society for 
Reproductive Medicine, Society for Reproductive Biologists 
and Technologists, and Society for Assisted Reproductive 
Technology [11]. 
Maintaining records online. Practice Committee of Society for Assisted Reproductive 
Technology; Practice Committee of American Society for 
Reproductive Medicine [12]. 
Wearing proper masks and PPE kits to stop cross-contamination.   Recommendation based on expert opinion. 
Vaccinating all staff on a priority basis. World Health Organization [13]. 
Preparing emergency contact list for all clinical and non-clinical 
staff. 
ESHRE Guideline Group on Good Practice in IVF Labs et 
al., 2016 [14].  
Educating the possible disease transmission and mitigation 
methods to all staff.  
Kuhar et al., 2019 [15].  
 
Summary and Conclusion  
COVID-19 pandemic has a severe risk for all healthcare 
workers and patients, including IVF laboratory workers. Any 
accidental exposure of contaminated fluids or materials poses a 
direct concern for IVF healthcare workers. Most of the standard 
operating procedures (SOP) are inadequate to face the aerosol-
mediated transmission of viruses. All SOPs should be revised  
 
 
following the national and local guidelines, with strict 
implementations to withstand future infections. Good 
collaboration between different units and team members is 
mandatory for smooth functioning when running IVF 
laboratories in times of crisis, such as the current COVID-19 
pandemic.  
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Table 2: Andrology laboratory recommendations during COVID-19  
Recommendation  Basis of evidence 
As a precautionary measure, all males starting their fertility 
treatments should be tested for COVID-19.  
Practice Committee of Society for Assisted Reproductive 
Technology; Practice Committee of American Society for 
Reproductive Medicine [12]. 
Fertility preservation should be considered invulnerable males, 
including males undergoing therapy and autoimmune and 
inflammatory treatments. 
Esteves et al [16]. 
Where planned, a proper dedicated area of semen collection and 
separate semen cryopreservation tank should be assigned. 
Andrabi et al [17]. 
A proper semen collection written instruction in local and national 
language should always be available in the collection room before 
sample collection to avoid in-person contact.  
Andrabi et al [17]. 
All andrology technicians/embryologists should strictly follow the 
standard operating protocols in handling the semen samples. 
Onigbinde et al [18]. 
Proper filtration systems should be installed in the form of mobile 
towers to increase air quality inside the andrology laboratory.  
Recommendation based on expert opinion 
All the materials used in performing andrological procedures 
should be disposed of immediately after the procedure, followed 
by thorough cleaning. 
Recommendation based on expert opinion 
In COVID-19 positive patients, home collection and proper care 
can be an ideal way. 
Recommendation based on expert opinion 
 
Table 3: Embryology laboratory recommendations during COVID-19 
Recommendation  Basis of evidence 
Avoiding in-person counseling and use of tele phone or email 
calling. Adequate time should be given between procedures when 
performing a thorough cleaning in ovum pickup areas. 
Andrabi et al [17]. 
Minimal embryology teams should be made available for worst-
case scenarios. 
Andrabi et al [17]. 
Extra care should be taken in follicular fluid handling during 
screening procedures, especially in COVID-19 infection recovered 
patients.  
Recommendation based on expert opinion 
After the proper follicular fluid screening, care should be taken in 
the form of non-spillage of fluid, proper closing of the lid, and 
immediate disposal should be taken care of. 
Recommendation based on expert opinion 
Pipette holders should be disinfected after every oocyte retrieval 
procedure. 
Recommendation based on expert opinion 
Although no cross-contamination of gametes or embryos has been 
reported yet; however, it is better to use a closed type vitrification 
system that avoids direct contact of embryos with liquid nitrogen. 
Porcu et al [19] 
A separate liquid nitrogen tank should store cryopreserved 
embryos and oocytes of patients having symptoms or tested 
positive for COVID-19. 
Recommendation based on expert opinion 
After every procedure, proper disinfection of the workstation and 
other equipment should be done with disinfectant, which is 
alcohol-free, non-VOC releasing, non-fragranced, and effective 
against bacteria, yeasts, viruses, and mycobactericidal. 
Alaluf et al [20] 
Although the chances of cross-contamination are very low in ART 
laboratories due to antibiotics in media and continuous washing of 
gametes repeatedly, every laboratory should properly follow its 
standard operating protocols. 
Onigbinde et al [18] 
 
Some other suggestions during this COVID-19 pandemic period 
include, following routine good laboratory practice, proper 
protection of staff, proper cleaning of safety cabinets with tested 
quaternary ammonium compounds lab disinfectants,  proper pre 
and post sanitization of all equipment, bed, trolley, and theatre 
(General suggestions). 
Recommendation based on expert opinion 
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Abbreviation  
COVID-19: Coronavirus Disease 19; WHO: World Health 
Organization; ART: Assisted Reproductive Techniques; IVF: In-Vitro 
Fertilization; SARS-CoV-2: Severe Acute Respiratory Coronavirus 2; 
ASRM: American Society for Reproductive Medicine; ESHRE: 
European Society of Human Reproduction and Embryology; BFS: 
British Fertility Society; ACE2: Angiotensin-Converting Enzyme 2; 
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